The unified social credit code/registration number of Hubei Merrill Lynch Pharmaceutical Co., Ltd. is 9 1420923553903437H, and the corporate legal person is Li Meilin. At present, the enterprise is in the state of opening.
The business scope of Hubei Merrill Lynch Pharmaceutical Co., Ltd. is: drug research and development, medical food research and development; Health products, biomedical technology research and development, technology transfer; Research and development and technology transfer of disinfection and sterilization products, sanitary products and cosmetics; Software technology development services; Production and sales of injections, oral preparations, drugs for external use, APIs, pharmaceutical excipients, pharmaceutical and chemical raw materials, medical devices, medical disinfectants and veterinary drug preparations; Warehousing and freight services (excluding dangerous goods); Production and sales of medical packaging materials, chemical products, chemical preparations, primary agricultural products, cosmetics, health food and medical food; Medical information consultation; Business information consultation (excluding securities and futures, business investigation and investment consultation); Enterprise management consulting; Exhibition service; Marketing promotion; Marketing planning; Product agent sales service; Import and export trade of goods or technologies, wholesale and retail of commodities. (Licensed projects can only be operated after obtaining the permission of relevant departments). In Hubei Province, the total registered capital of companies with similar business scope is 5710.03 million yuan, and the main capital is concentrated in enterprises with a scale of over 50 million and 1.00- 1.00 million, * *1.654,38+0.07. In the province, the registered capital of enterprises is excellent.
See more information and materials of Hubei Merrill Lynch Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.